DeepMed Research

Jonsson Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.ucla.edu

Clinical Trials

Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-01-08

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 7

Registration Number: NCT00020800

Locations: 🇸🇪
Huddinge University Hospital, Stockholm, Sweden
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Barrett Cancer Center, Cincinnati, Ohio, United States

and more 15 locations

BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer

Phase 2

Withdrawn

Conditions: Stage IV Renal Cell Cancer
Recurrent Renal Cell Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-07-10

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00040989

Locations: 🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸
Norris Cotton Cancer Center, Lebanon, New Hampshire, United States
🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States

and more 23 locations

Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-01-27

Last Posted Date: 2013-07-10

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00045318

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Cancer Therapy and Research Center, San Antonio, Texas, United States
🇺🇸
Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, United States

and more 2 locations

STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia

Phase 1

Completed

Conditions: Leukemia

First Posted Date: 2003-01-27

Last Posted Date: 2013-06-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00015860

Locations: 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

and more 2 locations

Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-09-20

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00020995

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy

Phase 3

Conditions: Ovarian Cancer
Primary Peritoneal Cavity Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-09-17

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00004115

Locations: 🇬🇧
Antisoma, London, England, United Kingdom

Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: celecoxib

First Posted Date: 2003-01-27

Last Posted Date: 2020-08-03

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 21

Registration Number: NCT00020878

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma

Phase 2

Conditions: Lymphoma

First Posted Date: 2003-01-27

Last Posted Date: 2013-12-19

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00042913

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Cryosurgery in Treating Women With Breast Lesions

Phase 1

Completed

Conditions: Breast Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-05-30

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00020852

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-05-15

Lead Sponsor: Jonsson Comprehensive Cancer Center

Registration Number: NCT00005079

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy